Clinical trial
Potential Role of Donor-derived Cell-Free DNA as a Biomarker in Cardiac Allograft Vasculopathy
NCT04791852 is registered in ClinicalTrials.gov with Puerta de Hierro University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Potential Role of Donor-derived Cell-Free DNA as a Biomarker in Cardiac Allograft Vasculopathy
- Lead sponsor
- Puerta de Hierro University Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 10, 2019
- Completion date
- April 15, 2021
- Enrollment
- 94 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cardiac allograft vasculopathy